<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Clinical Ophthalmology</journal-id><journal-title-group><journal-title>Clinical Ophthalmology (Auckland, N.Z.)</journal-title></journal-title-group><issn pub-type="ppub">1177-5467</issn><issn pub-type="epub">1177-5483</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28182152</article-id><article-id pub-id-type="pmc">5279846</article-id><article-id pub-id-type="doi">10.2147/OPTH.S123150</article-id><article-id pub-id-type="publisher-id">opth-11-219</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Trypan blue-assisted posterior capsulorhexis in pediatric cataract surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lotfy</surname><given-names>Ayman</given-names></name><xref ref-type="aff" rid="af1-opth-11-219">1</xref><xref ref-type="aff" rid="af2-opth-11-219">2</xref><xref ref-type="corresp" rid="c1-opth-11-219"/></contrib><contrib contrib-type="author"><name><surname>Abdelrahman</surname><given-names>Ayman</given-names></name><xref ref-type="aff" rid="af1-opth-11-219">1</xref><xref ref-type="aff" rid="af2-opth-11-219">2</xref></contrib></contrib-group><aff id="af1-opth-11-219"><label>1</label>Ophthalmology Department, Zagazig University Hospital</aff><aff id="af2-opth-11-219"><label>2</label>Alpha Vision Center, Zagazig, Egypt</aff><author-notes><corresp id="c1-opth-11-219">Correspondence: Ayman Lotfy, Ophthalmology Department, Zagazig University Hospital, Koliat Al Tob Street, Shaibet an Nakareyah, Markaz El-Zagazig, Ash Sharqia Governorate 44519, Egypt, Tel +20 102 220 4510, Fax +20 122 427 6447, Email <email>elnadyayman@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>24</day><month>1</month><year>2017</year></pub-date><volume>11</volume><fpage>219</fpage><lpage>222</lpage><permissions><copyright-statement>&#x000a9; 2017 Lotfy and Abdelrahman. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2017</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To evaluate the safety and efficacy of staining the posterior capsule with trypan blue during capsulorhexis in pediatric cataract surgery.</p></sec><sec><title>Patients and methods</title><p>This was a prospective randomized comparative study carried out at Alpha Vision Center, Zagazig, Egypt. This study included 2 groups of children with pediatric cataract randomly allocated to undergo irrigation and aspiration. In the trypan group, which included 11 eyes, trypan blue was used to stain the posterior capsule during posterior capsulorhexis. In the control group, which included 10 eyes, no staining was performed. All surgeries were performed by the same surgeon. The 2 groups were compared for criteria such as completion of capsulorhexis, disruption of vitreous face and in-the-bag intraocular lens implantation.</p></sec><sec><title>Results</title><p>This study included 21 eyes of 16 patients (age range: 6 months&#x02013;4 years). A statistically significant difference was observed for the following parameters between the 2 groups: capsulorhexis completion (<italic>P</italic>=0.04), vitreous face disruption (<italic>P</italic>=0.01) and in-the-bag intraocular lens implantation (<italic>P</italic>=0.022).</p></sec><sec><title>Conclusion</title><p>This study suggests that staining of the posterior capsule during capsulorhexis in pediatric cataract operation gives better results than capsulorhexis without staining. The stain changes the capsule texture making capsulorhexis easier with fewer complications.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>staining</kwd><kwd>capsulorhexis</kwd><kwd>pediatric</kwd><kwd>cataract</kwd><kwd>trypan</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The major preventable cause of visual impairment during childhood is pediatric cataract.<xref rid="b1-opth-11-219" ref-type="bibr">1</xref> A clear visual axis is the optimal surgical outcome of the pediatric cataract.<xref rid="b2-opth-11-219" ref-type="bibr">2</xref> The visual axis may be obstructed by opacification of posterior capsule and hyaloid face and by inflammatory membranes.<xref rid="b3-opth-11-219" ref-type="bibr">3</xref> Posterior capsule opacification (PCO) is a common postoperative complication after pediatric cataract surgery with 100% risk.<xref rid="b4-opth-11-219" ref-type="bibr">4</xref> Multiple procedures have been used to prevent PCO and maintain a clear visual axis. These techniques include lensectomy with anterior vitrectomy, posterior capsulorhexis and intraocular lens (IOL) optic capture.<xref rid="b5-opth-11-219" ref-type="bibr">5</xref> Posterior capsulorhexis is considered to be difficult as the capsule is thin and fragile.<xref rid="b6-opth-11-219" ref-type="bibr">6</xref> Trypan blue has been used for anterior capsule staining in white cataracts<xref rid="b7-opth-11-219" ref-type="bibr">7</xref> and also for performing posterior capsulorhexis in pediatric cataract in order to change the nature of the capsule and facilitate visualization. Use of trypan blue allows better controlled posterior capsulorhexis and facilitates optic capture of the IOL, thus providing better centration and consequently better optical performance.<xref rid="b8-opth-11-219" ref-type="bibr">8</xref>,<xref rid="b9-opth-11-219" ref-type="bibr">9</xref></p></sec><sec sec-type="methods|subjects"><title>Patients and methods</title><p>This study, carried out at Alpha Vision Center, Zagazig, Egypt, was performed according to the Declaration of Helsinki and was approved by the institutional review board of Alpha Vision Center. Written informed consent was obtained from the guardian of each patient (<xref ref-type="supplementary-material" rid="SD1-opth-11-219">Figure S1</xref>). This study included 21 eyes of 16 patients with congenital cataract. They were randomly divided into 2 groups: group A, the trypan group that included 11 eyes, and group B, the control group that included 10 eyes. Of the 16 patients, ages ranged from 6 months to 4 years, 9 were males, and 7 were females. All the patients underwent complete ophthalmic examination with posterior segment evaluation. All the cases were operated by the same surgeon.</p><sec><title>Surgical technique</title><p>All the patients in both the groups were operated under general anesthesia. A corneal tunnel was made by 2.8 mm keratome, and 2 paracentesis were made by 20 G micro vitreoretinal blade. Viscoelastic material (Healon<sup>&#x000ae;</sup>; Abbot Medical Optics Inc., Santa Ana, CA, USA) was injected into the anterior chamber, and capsulorhexis was performed using forceps (in cases with white cataract the rhexis was done after staining the anterior capsule with trypan blue). The lens matter was removed by bimanual irrigation aspiration. In group A, the posterior capsule was stained by injection of an air bubble and then 0.1 mL of trypan blue (VisionBlue<sup>&#x000ae;</sup>; DORC, Zuildland, the Netherlands) was instilled under the air bubble. The dye was then washed with a balanced salt solution. High-viscosity viscoelastic was instilled both in front of and into the capsular bag. A cystotome was used to create an opening in the posterior capsule. Healon was then instilled behind the posterior capsule to create a plane between the posterior capsule and the vitreous face. The needle was then used to hook, lift and tear the capsule to create a triangular opening and capsular flap. Capsulorhexis was then completed using rhexis forceps. In group B, posterior capsulorhexis was done without staining with the dye. After opening the posterior capsule, the vitrector port was inserted below the posterior capsule. An anterior vitrectomy was performed to remove a core of the vitreous from the visual axis. A foldable 3-piece hydrophobic acrylic IOL was then implanted in-the-bag and the wounds were sutured with subconjunctival injection of antibiotic and steroids. The 2 groups were compared for completion of capsulorhexis, disruption of vitreous face and implantation of IOL (in sulcus or in-the-bag) (<xref ref-type="fig" rid="f1-opth-11-219">Figure 1</xref>). All the cases were followed up for 1 year for detection of PCO.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Data analysis was performed using SPSS for Windows (version 17.0; SPSS Inc., Chicago, IL, USA). Chi-squared test was used to statistically analyze the results between the 2 groups, and the level of significance was set at <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Preoperative data are shown in <xref ref-type="table" rid="t1-opth-11-219">Table 1</xref>. In group A, rhexis was completed in 10 cases (91%) whereas in group B, which was not stained, rhexis was completed in only 2 cases (20%) which showed statistically significant difference (<italic>P</italic>=0.04). The anterior vitreous was disrupted in only 1 case (9%) in group A and in 3 cases (30%) in group B (<italic>P</italic>=0.01; significantly different). IOL was implanted in-the-bag in 10 cases (91%) in group A and in 7 cases (70%) in group B with a statistically significant difference (<italic>P</italic>=0.022). The patients were followed up for 12 months to check whether they have developed PCO, which was not detected in both the groups. Intraoperative and postoperative data are shown in <xref ref-type="table" rid="t2-opth-11-219">Table 2</xref>.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Posterior capsulorhexis in pediatric cataract surgery has the advantage of decreasing the incidence of posterior capsular opacification postoperatively. In this study, we found it easier to visualize the posterior capsule after staining with trypan blue. Also, it was easier to properly control posterior capsulorhexis as the stained capsule was less elastic. This has been reflected in the results. Posterior capsulorhexis was completed in 91% of the cases in group A (where the dye was used) and in 80% of the cases in group B (rhexis without dye).<xref rid="b10-opth-11-219" ref-type="bibr">10</xref> Sharma et al<xref rid="b11-opth-11-219" ref-type="bibr">11</xref> used trypan blue-assisted capsulorhexis with IOL optic capture. They reported that rhexis was completed in 94.4% of the cases when the dye was used compared with 64.7% when it was not used.<xref rid="b11-opth-11-219" ref-type="bibr">11</xref> In a randomized study by Saini et al<xref rid="b12-opth-11-219" ref-type="bibr">12</xref> that included 44 eyes, 25 eyes were operated using trypan blue dye and 19 eyes without the stain; the results showed that in the group that used the dye, 82.6% of the cases had complete posterior rhexis, whereas in the group that did not use the dye, only 52.6% of cases had complete rhexis. Ivanka and Valentina<xref rid="b13-opth-11-219" ref-type="bibr">13</xref> reported the occurrence of posterior capsular opacification in 7 cases (21%). In this work, disruption of the anterior vitreous face occurred in 1 eye (10%) in group A and in 3 eyes (30%) in group B. Our results are comparable with the results published by Dholakia et al<xref rid="b14-opth-11-219" ref-type="bibr">14</xref> who studied the disturbance of vitreous face in congenital cataract and reported vitreous face disruption in 4.7% of eyes and in-the-bag IOL implantation in 92.5% of cases. In this study, in-the-bag IOL implantation was performed in 91% of cases in group A and in 70% of cases in group B.</p></sec><sec><title>Conclusion</title><p>Trypan blue-assisted posterior capsulorhexis is of advantage in pediatric cataract surgery. The dye helps in the completion of rhexis with safer in-the-bag IOL implantation and less postoperative PCO.</p><p>The limitation of this study is the small number of cases and the lack of objective measures for capsule elasticity.</p></sec><sec sec-type="supplementary-material"><title>Supplementary material</title><supplementary-material content-type="local-data" id="SD1-opth-11-219"><label>Figure S1</label><caption><p>Consent for operation.</p></caption><media mimetype="image" mime-subtype="tif" xlink:href="opth-11-219s1.tif" xlink:type="simple" id="d35e256" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>The abstract of this paper was presented at the World Ophthalmology Congress; 2012 (Abu Dhabi, United Arab Emirates).<xref rid="b15-opth-11-219" ref-type="bibr">15</xref></p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-opth-11-219"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasavada</surname><given-names>AR</given-names></name><name><surname>Praveen</surname><given-names>MR</given-names></name><name><surname>Tassignon</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Posterior capsule management in congenital cataract surgery</article-title><source>J Cataract Refract Surg</source><year>2011</year><volume>37</volume><issue>1</issue><fpage>173</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">21183112</pub-id></element-citation></ref><ref id="b2-opth-11-219"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>D</given-names></name><name><surname>Wright</surname><given-names>KW</given-names></name><name><surname>Amaya</surname><given-names>L</given-names></name><name><surname>Cassidy</surname><given-names>L</given-names></name><name><surname>Nischal</surname><given-names>K</given-names></name><name><surname>Russell-Eggitt</surname><given-names>I</given-names></name></person-group><article-title>Should we aggressively treat unilateral congenital cataracts?</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><issue>9</issue><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">11520768</pub-id></element-citation></ref><ref id="b3-opth-11-219"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram</surname><given-names>J</given-names></name><name><surname>Brar</surname><given-names>GS</given-names></name><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name></person-group><article-title>Role of posterior capsulotomy with vitrectomy and intraocular lens design and material in reducing posterior capsule opacification after pediatric cataract surgery</article-title><source>J Cataract Refract Surg</source><year>2003</year><volume>29</volume><issue>8</issue><fpage>1579</fpage><lpage>1584</lpage><pub-id pub-id-type="pmid">12954310</pub-id></element-citation></ref><ref id="b4-opth-11-219"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight-Nanan</surname><given-names>D</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>M</given-names></name><name><surname>Bowell</surname><given-names>R</given-names></name></person-group><article-title>Outcome and complications of intraocular lenses in children with cataract</article-title><source>J Cataract Refract Surg</source><year>1996</year><volume>22</volume><issue>6</issue><fpage>730</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">8844387</pub-id></element-citation></ref><ref id="b5-opth-11-219"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>SK</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Trivedi</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Pediatric cataract surgery and intraocular lens implantation: current techniques, complications, and management</article-title><source>Int Ophthalmol Clin</source><year>2001</year><volume>41</volume><issue>3</issue><fpage>175</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">11481546</pub-id></element-citation></ref><ref id="b6-opth-11-219"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argento</surname><given-names>C</given-names></name><name><surname>Badoza</surname><given-names>D</given-names></name><name><surname>Ugrin</surname><given-names>C</given-names></name></person-group><article-title>Optic capture of the AcrySof intraocular lens in pediatric cataract surgery</article-title><source>J Cataract Refract Surg</source><year>2001</year><volume>27</volume><issue>10</issue><fpage>1638</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">11687364</pub-id></element-citation></ref><ref id="b7-opth-11-219"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhartiya</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Ray</surname><given-names>M</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Vajpayee</surname><given-names>RB</given-names></name></person-group><article-title>Trypan blue assisted phacoemulsification in corneal opacities</article-title><source>Br J Ophthalmol</source><year>2002</year><volume>86</volume><issue>8</issue><fpage>857</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">12140203</pub-id></element-citation></ref><ref id="b8-opth-11-219"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menapace</surname><given-names>R</given-names></name></person-group><article-title>Posterior capsulorhexis combined with optic buttonholing: an alternative to standard in-the-bag implantation of sharp-edged intraocular lenses? A critical analysis of 1000 consecutive cases</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2008</year><volume>246</volume><issue>6</issue><fpage>787</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">18425525</pub-id></element-citation></ref><ref id="b9-opth-11-219"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Vajpayee</surname><given-names>RB</given-names></name></person-group><article-title>Trypan-blue-assisted posterior capsule plaque removal</article-title><source>J Cataract Refract Surg</source><year>2002</year><volume>28</volume><issue>6</issue><fpage>916</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">12036618</pub-id></element-citation></ref><ref id="b10-opth-11-219"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grieshaber</surname><given-names>MC</given-names></name><name><surname>Pienaar</surname><given-names>A</given-names></name><name><surname>Stegmann</surname><given-names>R</given-names></name></person-group><article-title>Posterior vertical capsulotomy with optic entrapment of the intraocular lens in congenital cataracts for prevention of capsular opacification</article-title><source>J Cataract Refract Surg</source><year>2005</year><volume>31</volume><issue>5</issue><fpage>886</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">15975452</pub-id></element-citation></ref><ref id="b11-opth-11-219"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Balasubramanya</surname><given-names>R</given-names></name><name><surname>Dada</surname><given-names>VK</given-names></name><name><surname>Vajpayee</surname><given-names>RB</given-names></name></person-group><article-title>Efficacy of trypan blue in posterior capsulorhexis with optic capture in pediatric cataracts</article-title><source>BMC Ophthalmol</source><year>2006</year><volume>21</volume><fpage>6</fpage><lpage>12</lpage></element-citation></ref><ref id="b12-opth-11-219"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>JS</given-names></name><name><surname>Jain</surname><given-names>AK</given-names></name><name><surname>Sukhija</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Saroha</surname><given-names>V</given-names></name></person-group><article-title>Anterior and posterior capsulorhexis in pediatric cataract surgery with or without trypan blue dye: randomized prospective clinical study</article-title><source>J Cataract Refract Surg</source><year>2003</year><volume>29</volume><issue>9</issue><fpage>1733</fpage><lpage>1737</lpage><pub-id pub-id-type="pmid">14522292</pub-id></element-citation></ref><ref id="b13-opth-11-219"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanka</surname><given-names>P</given-names></name><name><surname>Valentina</surname><given-names>LL</given-names></name></person-group><article-title>Surgical technique and postoperative complications in pediatric cataract surgery: retrospective analysis of 21 cases</article-title><source>Croat Med J</source><year>2004</year><volume>45</volume><issue>3</issue><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">15185419</pub-id></element-citation></ref><ref id="b14-opth-11-219"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dholakia</surname><given-names>SA</given-names></name><name><surname>Praveen</surname><given-names>MR</given-names></name><name><surname>Vasavada</surname><given-names>AR</given-names></name><name><surname>Nihalani</surname><given-names>B</given-names></name></person-group><article-title>Completion rate of primary posterior continuous curvilinear capsulorhexis and vitreous disturbance during congenital cataract surgery</article-title><source>J AAPOS</source><year>2006</year><volume>10</volume><issue>4</issue><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">16935237</pub-id></element-citation></ref><ref id="b15-opth-11-219"><label>15</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Lotfy</surname><given-names>A</given-names></name><name><surname>Abdelrahman</surname><given-names>A</given-names></name></person-group><source>Trypan blue-assisted posterior capsulorhexis in pediatric cataract surgery</source><conf-name>Abstract presented at: World Ophthalmology Congress 2012</conf-name><conf-date>16&#x02013;20, February 2012</conf-date><conf-loc>Abu Dhabi, United Arab Emirates</conf-loc></element-citation></ref></ref-list></back><floats-group><fig id="f1-opth-11-219" position="float"><label>Figure 1</label><caption><p>Intraoperative data.</p><p><bold>Notes:</bold> Group A, the trypan group that included 11 eyes; group B, the control group that included 10 eyes.</p><p><bold>Abbreviation:</bold> IOL, intraocular lens.</p></caption><graphic xlink:href="opth-11-219Fig1"/></fig><table-wrap id="t1-opth-11-219" position="float"><label>Table 1</label><caption><p>Preoperative data</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Group A</th><th valign="top" align="left" rowspan="1" colspan="1">Group B</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of eyes</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of patients</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Male</td><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Female</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="left" rowspan="1" colspan="1">32&#x000b1;2.1 months</td><td valign="top" align="left" rowspan="1" colspan="1">30&#x000b1;3.2 months</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-opth-11-219"><p><bold>Notes:</bold> Group A, the trypan group that included 11 eyes; group B, the control group that included 10 eyes.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-opth-11-219" position="float"><label>Table 2</label><caption><p>Intraoperative and postoperative data</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" align="left" colspan="1">Outcome parameters</th><th colspan="2" valign="top" align="left" rowspan="1">Group A
<hr/></th><th colspan="2" valign="top" align="left" rowspan="1">Group B
<hr/></th><th rowspan="2" valign="top" align="left" colspan="1"><italic>P</italic>-value</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">N</th><th valign="top" align="left" rowspan="1" colspan="1">%</th><th valign="top" align="left" rowspan="1" colspan="1">N</th><th valign="top" align="left" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Completion of rhexis</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">91</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">80</td><td valign="top" align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disruption of anterior vitreous</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">30</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">In-the-bag IOL implantation</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">91</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">70</td><td valign="top" align="left" rowspan="1" colspan="1">0.022</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-opth-11-219"><p><bold>Notes:</bold> Group A, the trypan group that included 11 eyes; group B, the control group that included 10 eyes.</p></fn><fn id="tfn3-opth-11-219"><p><bold>Abbreviation:</bold> IOL, intraocular lens.</p></fn></table-wrap-foot></table-wrap></floats-group></article>